Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-20-003438
Filing Date
2020-03-30
Accepted
2020-03-30 16:30:49
Documents
98
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp-10k_123119.htm 10-K 1559838
2 DESCRIPTION OF CAPITAL STOCK ex4-6.htm EX-4.6 63350
3 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-1.htm EX-23.1 3818
4 CERTIFICATION BY CEO PURSUANT TO SECTION 302 ex31-1.htm EX-31.1 14633
5 CERTIFICATION BY CFO PURSUANT TO SECTION 302 ex31-2.htm EX-31.2 14673
6 CERTIFICATION BY CEO PURSUANT TO SECTION 906 ex32-1.htm EX-32.1 7140
7 CERTIFICATION BY CFO PURSUANT TO SECTION 906 ex32-2.htm EX-32.2 7009
  Complete submission text file 0001387131-20-003438.txt   6740013

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT admp-20191231.xml EX-101.INS 1138412
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20191231.xsd EX-101.SCH 54861
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20191231_cal.xml EX-101.CAL 96846
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20191231_def.xml EX-101.DEF 273696
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20191231_lab.xml EX-101.LAB 497310
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20191231_pre.xml EX-101.PRE 418522
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36242 | Film No.: 20757520
SIC: 2834 Pharmaceutical Preparations